Freek Verheugt reviews the knowns and unknowns in this tricky-to-manage patient group.

C. Michael Gibson discusses the late-breaking trial results with Ziad Ali.

Listen to C. Michael Gibson in conversation with Giulio Guagliumi.

C. Michael Gibson talks with Robert Califf about the future of clinical trials.